NASDAQ · Healthcare · Medical - Devices
Anika Therapeutics, Inc.
ANIK
Anika Therapeutics, Inc. CEO Stephen D. Griffin · Market cap $192.3M.
$14.45
-0.23 · -1.55%
52w hi $16.2452w lo $7.87
Off 52w high 8.8%
66
NOTABLE
Current InsiderScore
Corp · 90d
2
2 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
1
0 strong · 1 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
2 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| May 01 | John B Henneman III | Buy | 5,000 | $14.66 | +$73K | 39 | |
| Apr 30 | Stephen D. Griffin | President and CEO | Buy | 12,200 | $12.29 | +$150K | 66 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay